Skip to main content

View full-text article in PMC

. 2022 Jun 16;27(4):e12958. doi: 10.1111/anec.12958

TABLE 2.

Lead location of maximal ECG parameter (%)

Outcome	Cohort	n	I	II	III	aVR	aVL	aVF	V1	V2	V3	V4	V5	V6	p‐value ^a
Rest/supine
Tp‐e	Derivation	n = 21	0.0%	0.0%	4.8%	0.0%	9.5%	0.0%	0.0%	4.8%	57.1%	23.8%	0.0%	0.0%	<.0001
Tp‐e	Validation	n = 20	0.0%	0.0%	0.0%	0.0%	5.0%	5.0%	5.0%	20.0%	60.0%	5.0%	0.0%	0.0%	<.0001
Tp‐e/QT	Derivation	n = 21	0.0%	0.0%	4.8%	0.0%	9.5%	0.0%	0.0%	9.5%	52.4%	23.8%	0.0%	0.0%	<.0001
Tp‐e/QT	Validation	n = 20	0.0%	0.0%	0.0%	0.0%	5.0%	0.0%	5.0%	20.0%	70.0%	0.0%	0.0%	0.0%	<.0001
Tp‐e/QTc	Derivation	n = 21	0.0%	0.0%	4.8%	0.0%	9.5%	0.0%	0.0%	9.5%	52.4%	23.8%	23.8%	0.0%	<.0001
Tp‐e/QTc	Validation	n = 20	0.0%	0.0%	0.0%	0.0%	5.0%	0.0%	5.0%	20.0%	70.0%	0.0%	0.0%	0.0%	<.0001
Standing
Tp‐e	Derivation	n = 21	0.0%	0.0%	5.0%	0.0%	5.0%	0.0%	5.0%	0.0%	40.0%	30.0%	10.0%	5.0%	<.0001
Tp‐e	Validation	n = 20	5.3%	0.0%	0.0%	0.0%	0.0%	0.0%	5.3%	21.1%	36.8%	21.1%	15.8%	0.0%	.0003
Tp‐e/QT	Derivation	n = 21	0.0%	0.0%	5.0%	0.0%	0.0%	0.0%	5.0%	0.0%	45.0%	30.0%	10.0%	5.0%	<.0001
Tp‐e/QT	Validation	n = 20	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	5.3%	21.1%	36.8%	21.1%	15.8%	0.0%	<.0001
Tp‐e/QTc	Derivation	n = 21	0.0%	0.0%	5.0%	0.0%	0.0%	0.0%	5.0%	0.0%	45.0%	30.0%	10.0%	5.0%	<.0001
Tp‐e/QTc	Validation	n = 20	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	5.3%	21.1%	42.1%	21.1%	10.5%	0.0%	<.0001

^{^a}

p‐value indicates distribution compared to uniform.